Merck KGaA taps Wellcome for cancer R&D; Synlogic banks $5M for microbiome research;

@FierceBiotech: Every year Women in Biotech gets a ton of readers, and this issue is no exception. Trending nicely. Report | Follow @FierceBiotech

@JohnCFierce: In a surprise move, Bristol-Myers drops U.S. approval plans for hep C drug. News | Follow @JohnCFierce

@DamianFierce: CRO INC Research files for a $150M IPO, following in the footsteps of $Q, $CTLT and PRA. SEC filing | Follow @DamianFierce

@EmilyMFierce: Programmed antibiotics kill drug-resistant bacteria. More from FierceBiotech Research | Follow @EmilyMFierce

> Merck KGaA is collaborating with London's Institute of Cancer Research and the Wellcome Trust to develop two cancer candidates targeting the PARP pathway. News

> Microbiomics outfit Synlogic has closed a $5 million A round, bringing in cash from the Bill & Melinda Gates Foundation alongside seeders Atlas Venture and New Enterprise Associates. More

> Second Genome has struck a deal with the Mayo Clinic to collaborate on microbiomic treatments for up to 8 indications, including inflammatory bowel disease, metabolic disorders and colorectal cancer. Item

> Northwest Biotherapeutics ($NWBO) has signed a deal to raise $11.5 million by selling new shares to an existing shareholder for $5.05 each. Release

> Biotech accelerator Allied Minds has launched Novare Pharmaceuticals, a new company focused on developing treatments for inflammatory disease. Story

Medical Device News

@FierceMedDev: ICYMI yesterday: Optos, NHS and academia in $16M partnership for eye disease diagnostic. Article | Follow @FierceMedDev

@VarunSaxena2: Larry Wood of Edwards "Everybody's embarrassed that we were the 43rd country to get TAVR." Around same time as Brazil, Albania. | Follow @VarunSaxena2

@EmilyWFierce: Scalability and cost could be potential hurdles to bringing experimental CAR T-cell therapies to patients. More from the WSJ | Follow @EmilyWFierce

@MichaelGFierce: From our Women in Biotech Feature: Adelene Perkins of $INFI says, "Our endeavor is by definition a team sport." More | Follow @MichaelGFierce

> NanoString teams up with Brigham and Women's Hospital for cancer Dx development. More

> Unilife inks 15-year deal with Sanofi for wearable injectors. Story

> GE promotes biz dev exec to head healthcare. Report

Pharma News

@FiercePharma: Top-read special report Monday: Top 10 pharma companies by employees - 2014. Feature | Follow @FiercePharma

@CarlyHFierce: One more time: Our latest special report, Top women in biotech 2014. Good stuff right here. Feature | Follow @CarlyHFierce

> Report: Financial conflicts sway studies of flu fighters Tamiflu and Relenza. More

> Sovaldi may be cost-effective, but the U.K. can't afford it, documents say. Article

Biotech Research News

> NIH doles out first $46M round of BRAIN Initiative grants. Report

> Gene therapy technique could treat rare lung disease. More

> Programmed antibiotics kill drug-resistant bacteria. Story

> Ebola genome browser launched to aid drug discovery. Article

> $19M in FDA grants will support rare disease research. Item

Pharma Manufacturing News

> Cipla works with partner to build a manufacturing plant in Iran. More

> West Pharmaceutical confirms it's building $126M facility in Ireland. Story

> Patheon to add almost 500 jobs over 5 years as it expands in NC. Article

> India's IPCA buys plant as it deals with FDA issues. Item

> New FDA concerns arise for Hospira plant in Australia. Report

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spin-out company SpringWorks has lost president and founder Lara Sullivan, M.D. who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.